Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1

Full metadata record
DC FieldValueLanguage
dc.contributor.authorMunshi, M.H.-
dc.contributor.authorSack, David A.-
dc.contributor.authorHaider, Khaleda-
dc.contributor.authorAhmed, Zia U.-
dc.contributor.authorRahaman, M.M.-
dc.contributor.authorMorshed, M.G.-
dc.date.accessioned2012-12-20T08:49:38Z-
dc.date.available2012-12-20T08:49:38Z-
dc.date.issued1987-
dc.identifier.citationLancet 1987 Aug 22;2(8556):419-21en
dc.identifier.urihttp://hdl.handle.net/123456789/4314-
dc.description.abstractIn an epidemic of shigellosis in southern Bangladesh the causal organism, Shigella dysenteriae type 1, was resistant to nalidixic acid as well as to co-trimoxazole (trimethoprimsulphamethoxazole) and ampicillin. The genes coding for resistance to nalidixic acid, but not those coding for resistance to co-trimoxazole or ampicillin, are located on a conjugative 20 megadalton plasmid. This epidemic is of particular importance because of the resistance to nalidixic acid, an antibiotic to which shigellae are seldom resistant, and because plasmids were previously thought not to mediate resistance to nalidixic aciden
dc.format.extent271626 bytes-
dc.format.mimetypeapplication/pdf-
dc.language.isoenen
dc.subjectAmpicillinen
dc.subjectBangladeshen
dc.subjectDNA, Bacterialen
dc.subjectDisease Outbreaksen
dc.subjectDrug Combinationsen
dc.subjectDysentery, Bacillaryen
dc.subjectEvaluation Studies as Topicen
dc.subjectTrimethoprim-Sulfamethoxazole Combinationen
dc.titlePlasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1en
dc.typeArticleen
Appears in Collections:A. Original papers

Files in This Item:
File Description SizeFormat 
1987-Lancet-419-MunshiMH.pdf265.26 kBAdobe PDFView/Open    Request a copy


This item is protected by original copyright